These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 14581837)
1. Life in the COPD straitjacket: improving lives of sufferers. Booker R Br J Nurs; 2003 Oct 9-22; 12(18):1061. PubMed ID: 14581837 [No Abstract] [Full Text] [Related]
2. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD? Hamilton T; Miller JB; Vincent EC; St Anna L J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909 [No Abstract] [Full Text] [Related]
8. [Indacaterol is a new once-daily beta2-agonist for treatment of COPD]. Ulrik CS Ugeskr Laeger; 2010 Nov; 172(47):3260-3. PubMed ID: 21092722 [TBL] [Abstract][Full Text] [Related]
9. [Inhalation steroids in COPD: of value only for asthma patients!]. Hien M MMW Fortschr Med; 2003 Oct; 145(44):16. PubMed ID: 14655500 [No Abstract] [Full Text] [Related]
10. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease]. Pedersen ST Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004 [No Abstract] [Full Text] [Related]
11. Too many options, too little choice in COPD? Drug Ther Bull; 2016 Feb; 54(2):13. PubMed ID: 26848017 [No Abstract] [Full Text] [Related]
13. [Trends in modern COPD therapy]. Krankenpfl J; 2005; 43(4-6):116. PubMed ID: 16171062 [No Abstract] [Full Text] [Related]
14. [Role of inhaled corticosteroids in the management of COPD]. Chazan R Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354 [No Abstract] [Full Text] [Related]
15. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
16. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes. Hanania NA Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470 [TBL] [Abstract][Full Text] [Related]
17. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)]. Gillissen A; Gessner C; Hoheisel G; Juergens U Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787 [TBL] [Abstract][Full Text] [Related]
18. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease. Jones PW Proc Am Thorac Soc; 2004; 1(3):167-70. PubMed ID: 16113430 [TBL] [Abstract][Full Text] [Related]
19. Drugs in clinical development for chronic obstructive pulmonary disease. Molfino NA Respiration; 2005; 72(1):105-12. PubMed ID: 15753645 [TBL] [Abstract][Full Text] [Related]
20. Combination of ICSs and LABAs should be used in the management of patients with COPD--the pro argument. Sin DD Can Respir J; 2004 Apr; 11(3):221-3. PubMed ID: 15124042 [No Abstract] [Full Text] [Related] [Next] [New Search]